# US 2025/0319104 A1 · Moisturizing cream for radiation dermatitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0319104 A1
- Document ID: US20250319104A1
- Status: Published application
- Kind: A1
- Application number: 18/999,718
- Filed: 2024-12-23
- Published: 2025-10-16
- Earliest claimed: 2023-12-29
- Inventors: Arthur W Perry
- Web page: https://patentgrep.com/patent/US20250319104A1

## CPC

- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/357: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 17/00: Drugs for dermatological disorders
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A topical formulation is provided for treating systems of radiation treatments that includes a moisturizer base, and a plurality of active ingredients that include a corticosteroid, silymarin, and epigallocatechin-3-gallate (EGCG).

## Claims

### Claim 1

A topical formulation having a pH in the range of 5-8, comprising a moisturizer base, and a plurality of active ingredients comprising a corticosteroid, silymarin, and epigallocatechin-3-gallate (EGCG).

### Claim 2 (depends on 1)

The topical formulation of claim 1, wherein the corticosteroid comprises 0.1 to 1 weight percent hydrocortisone.

### Claim 3 (depends on 1)

The topical formulation of claim 1, wherein the corticosteroid comprises at least one selected from the group consisting of aclometasone, diproprionate, amcinonide, augmented betamethasone dipropionate betamethasone valerate, betamethasone diproprionate, clobetasol proprionate, clocortolone pivalate, desonide, desoximetasone, diflorasone, diacetate, fluandrenolide, fluocinolone acetonide, fluocinonide, fluticasone, propionate, halcinonide, halobestasol, propionate, hydrocortisone butyrate, methyl prednisolone, mometasone furoate, prednicarbate, and triamcinolone acetonide and wherein a concentration of the corticosteroid is 0.01 to 1 weight percent.

### Claim 4 (depends on 1)

The topical formulation of claim 1, wherein the moisturizer base comprises a mixture of an emollient, a humectant, a ceramide, and an occlusive.

### Claim 5 (depends on 4)

The topical formulation of claim 4, wherein the moisturizer base comprises at least three lipid components.

### Claim 6 (depends on 5)

The topical formulation of claim 5, wherein the at least three lipid components comprise a ceramide, cholesterol, and a free fatty acid.

### Claim 7 (depends on 4)

The topical formulation of claim 4, wherein the humectant comprises at least one of glycerin, a mucopolysaccharide, and panthenol.

### Claim 8 (depends on 4)

The topical formulation of claim 4, wherein the emollient comprises at least one of olive oil, jojoba oil, safflower oil, an olive derived squalene oil. dimethicone, and saturated fatty alcohols.

### Claim 9 (depends on 4)

The topical formulation of claim 4, wherein the occlusive comprises at least one of cyclomethicone, a polyunsaturated lipid, and a phospholipid.

### Claim 10 (depends on 1)

The topical formulation of claim 1, wherein the epigallocatechin-3 Gallate (EGCG) has a concentration of 0.01 to 0.1 weight percent.

### Claim 11 (depends on 1)

The topical formulation of claim 1, wherein the silymarin has a concentration of 0.1 to 10 weight percent.

### Claim 12 (depends on 1)

The topical formulation of claim 1, wherein the active ingredients comprise a mixture of:
EGCG 95% Epigallocatechin Gallatyl Glucoside 0.03 weight percent,
hydrocortisone, and
silymarin 1 weight percent, the formulation further comprising 0.1 weight percent to 5 weigh percent of each of:
Lecithin (phosphatidylcholine)
Phytosphingosine,
Cholesterol,
Glycerin,
Olive oil,
Safflower oil,
Squalene (olive),
Sodium Hyaluronate,
Jojoba Oil,
Ceramide,
Panthenol,
DL alpha-tocopherol in soybean oil,
PPG-3 Benzyl Ether Myristate,
Sodium Steroyl Glutamate,
Cetearyl Alcohol and Cetearyl Glucoside,
Cetyl Alcohol,
Arachidyl Alcohol, Behenyl Alcohol, Arachidyl glucoside’
Dicaprylyl Carbonate, and
Xanthan Gum.

### Claim 13

A method for treating symptoms of radiation treatment comprising applying a formulation having a pH in the range of 5-8 to skin topically at a site of interest, the formulation comprising a moisturizer base, and a plurality of active ingredients comprising a corticosteroid, silymarin, and epigallocatechin-3-gallate (EGCG), the method further comprising reapplying the formulation to the skin every 5 to 16 hours during the radiation treatment, and reapplying the formulation to the skin after a 4 day drug holiday.

### Claim 14 (depends on 13)

The method of claim 13, wherein the formulation is applied 3 to 8 weeks after the 4 day drug holiday.

### Claim 15 (depends on 13)

The method of claim 13, wherein the formulation is applied under an occlusive covering.

### Claim 16

A method for manufacturing the formulation for treating symptoms of radiation treatment comprising:
mixing Cetyl Alcohol, Montanov 68, Montanov 202, ceramide 2, Crodamol STS, ECGC, Cetiol CC, cholesterol, lecithin, and phytosphingosine in a vessel;
mixing water, Eumulgin SG, D-panthenol, hyaluronic acid, benzyl alcohol and Euxyl PE in a second vessel one at a time until dissolved, and adding xanthan gum under high shear;
combining content of the first and second vessel;
mixing water, coco caprylate, safflower seed oil, olive fruit oil, jojoba oil, cetearyl alcohol, glycerin, xanthan gum, benzyl alcohol, phenoxyethanol, and ethylhexylglycerin in a third vessel, and adding content of the third vessel to the combined first and second vessel;
mixing tocopherol and soybean oil in a fourth vessel, and combining content of the fourth vessel with the combined first, second, and third vessel; and
mixing silymarin, glycerin, and water in a fifth vessel and combining the content of the fifth vessel with the combined first, second, third, and fourth vessel to form a final mixture.

### Claim 17 (depends on 16)

A method of claim 16, comprising loading the final mixture into an airless pump that delivers a range of 1-1.5 ml of cream per pump.
